 4. Male or female patients at least 18 years old. Female patients must not be pregnant or breast feeding and must be practicing a medically acceptable form of birth control, be sterile, or post-menopausal. Females of childbearing potential FCBP is defined as premenopausal women capable of becoming pregnant. This includes women who are post-menopausal for at least 12 months after the last menses. FCBP must agree to use a medically acceptable form of birth control during the study and for at least 6 months after discontinuation of Erbitux or study medication. Females must agree not to breast feed during the study and for at least two months after discontinuation of Erbitux or study medication. Male patients should be using a double barrier protection method that is a medically acceptable form of birth control during the study or be sterile. 